Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levcromakalim in Migraine With Aura
NCT04012047Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Jul 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levcromakalim in migraine with aura (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoints: Headache Intensity, Incidence of Migraine and 1 more. Started Jul 2019; status: completed.
02
Drugs
levcromakalim
03
Conditions
migraine with aura
Beyond the preview
Go deeper on NCT04012047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04012047.